HIV/AIDS News Alert!

Adult and Adolescent Opportunistic Infections Guidlines Updated

The following sections of the Guidelines for the Prevemtion and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents have recently been updated:

Hepatitis B Virus infection: This section was updated to include TAF/FTC as a treatment option for patients with HBV/HIV coinfection. Data on the virologic efficacy of TAF for the treatment of HBV in persons without HIV infection and TAF/FTC in persons with HBV/HIV coinfection are discussed.
The panel no longer recommends adefovir or telbivudine as options for HBV/HIV coinfected patients, as there is limited safety and efficacy data on their use in this population. In addition, these agents have a higher incidence of toxicities than other recommended treatments.

Bacterial Enteric Infections This revision highlights new data from the CDC Health Advisory Network (April, 2017) indicating growing concern over fluoroquinolone resistant in Shigella isolates. Fluoroquinolones should only be used to treated Shigella isolates when the MIC<0.12 ug/mL. Reflex cultures ofstools positive for Shigella spp. by culture-independent diagnostic tests is required for antibiotic sensitivity testing.

Introducing the National HIV, HIV/HCV Co-Infection, and STD Curricula

The National HIV Curriculum (NHC) is a new and free online training platform designed to meet the core competency knowledge for HIV prevention, screening, diagnosis, and ongoing treatment and care. The curriculum is for healthcare professionals, students, and faculty and offers activities for novice to expert learners. The NHC provides ongoing, up-to-date information needed to meet the core competency knowledge for HIV prevention, screening, diagnosis, and ongoing treatment and care to healthcare professionals in the United States.

The NHC site is funded by HRSA's HIV/AIDS Bureau and was developed by the AIDS Education & Training Center's (AETC) National Coordinating Resource Center (NCRC) and the University of Washington. The website, which offers CME and CNE credits, contains course modules on the following topics:
Screening and Diagnosis
Basic HIV Primary Care
Antiretroviral Therapy
Co-Occuring Conditions

National HIV Curriculum: https://aidsetc.org/nhc
National HIV Curriculum Course Modules: http://www.hiv.uw.edu/
Click here for poster/flyer.

HIV/HCV Co-Infection:
An AETC National Curriculum

The HIV/HCV Co-Infection National Curriculum offers an evidence-based online curriculum for healthcare professionals and trainers to increase their knowledge on human immunodeficiency virus (HIV) and hepatitis C virus (HCV) co-infection among people of color in the United States and its territories. Topics covered include prevention, screening, diagnosis and treatment recommendations as well as barriers and other co-factors that may impede optimal treatment outcomes for co-infected people of color. National HIV/HCV Curriculum: https://aidsetc.org/hivhcv

National STD Curriculum

The National STD Curriculum addresses the epidemiology, pathogenesis, clinical manifestations, diagnosis, management, and prevention of STD's inculing chlamydia, gonorrhea, HSV, HPV, PID, syphilis, and vaginitis. This is a free educational curriculum offered by the University of Washington STD Prevention and Training Center and the University of Washington and funded by a grant from the Centers for Disease Control and Prevention (CDC). National STD Curriculum: http://www.std.uw.edu/

National rapid response for HIV management and bloodborne pathogen exposures

The Clinician Consultation Center is a free telephone advice service for clinicians by clinicians. Receive expert clinical advise on HIV, hepatitis C, substance abuse, PrEP, PEP, and perinatal HIV. See nccc.ucfs.edu for more information.

HIV/AIDS Warmline: 800-933-3413
HIV treatment, ARV decisions, complications, and co-morbidities
Hepatitis C Warmline: 844-HEP-INFO (844-437-4636)
HCV testing, staging, monitoring, treatment
Substance Use Warmline: 855-300-3595
Substance use evaluation and management
Perinatal HIV Hotline: 888-448-8765
Pregnant women with HIV or at-risk for HIV & their infants
PrEPline: 855-HIV-PrEP
Pre-exposure prophylaxis for persons at risk for HIV
PEPline: 888-448-4911
Occupational & non-occupational exposure management